CTSO vs HPQ · rev $18.5M vs P/E 8.6, rev $44.52B
Cytosorbents Crp (CTSO) versus HP Inc (HPQ) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.
Latest reported HPQ revenue for 2026-07-31 was $44.52B. Net income was $1.66B. Revenue was up 54.3% from 2026-04-30 to 2026-07-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
CTSO currently screens at market cap $28.8M. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Not investment advice. Open the CTSO and HPQ stock pages for the full models.
Not investment advice.